Owlet (OWLT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Jun, 2026Executive summary
Annual meeting scheduled for August 12, 2026, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by August 11, 2026.
Voting matters and shareholder proposals
Election of two directors, Marc Stoll and Kurt Workman, for terms expiring in 2029.
Advisory vote to approve executive compensation for 2025.
Advisory vote on the frequency of future say-on-pay votes (every one, two, or three years).
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
Approval of an amendment to the 2021 Incentive Award Plan.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Owlet
- Strong retail, international, and medical channel growth, with digital health and subscription expansion.OWLT
TD Cowen 45th Annual Healthcare Conference9 Jul 2026 - Shareholders will vote on director elections, executive pay, auditor ratification, and an expanded incentive plan.OWLT
Proxy filing30 Jun 2026 - Subscription growth, telehealth launch, and AI-driven efficiency drive profitability and focus.OWLT
46th Annual William Blair Growth Stock Conference3 Jun 2026 - Subscription and AI-driven health insights fuel growth, with FDA clearance as a key differentiator.OWLT
TD Cowen 10th Annual Future of the Consumer Conference2 Jun 2026 - Q1 2026 revenue up 6.4% to $22.5M, with record subscriptions and improved margins.OWLT
Q1 202611 May 2026 - Record revenue and FDA-cleared status drive growth in pediatric health monitoring.OWLT
Investor presentation1 Apr 2026 - Up to 9.6 million shares registered for resale by major holders; no proceeds to the company.OWLT
Registration Filing10 Mar 2026 - Record revenue, margin, and subscriber growth; strong 2026 outlook with global and AI expansion.OWLT
Q4 20255 Mar 2026 - Q1 revenue up 43% with record margin, breakeven EBITDA, and raised guidance amid ongoing risks.OWLT
Q1 20253 Feb 2026